In 2023, China's coal consumption in the manufacture of medicines stood at 735.95 ten thousand metric tons. The forecasted data from 2024 to 2028 shows a marginal annual increase, with values rising to 736.6 by 2028. The year-on-year growth rate averages around 0.02%, indicating a steady but minimal upward trend. Over the five-year period, this reflects an almost negligible compound annual growth rate, underscoring a relatively stable consumption pattern.
Future trends to watch:
- Potential policy shifts towards greener alternatives that could impact coal reliance in medicine production.
- Technological advancements in energy efficiency within the pharmaceutical industry.
- Global market changes affecting raw material and energy supply chains to China’s medicine sector.
